Psoriasis is an autoimmune disease that causes red patches and silvery scales on the skin, often accompanied by itching and pain. The disease is characterized by recurrent flare-ups and a chronic course, influenced by genetic, environmental, and immune factors. In severe cases, it can significantly impact patients’ physical health and psychological well-being.
In Europe and North America, the prevalence of psoriasis is relatively high, affecting about 2% to 3% of the population, influenced by climate and genetic factors. In Southeast Asian countries, prevalence is lower, but with accelerating urbanization and lifestyle changes, the number of psoriasis patients is increasing year by year. Differences in healthcare resources across regions affect treatment outcomes and disease management.
1. Significant skin damage
Patients with psoriasis often present with extensive erythema and thick scales, which severely affect appearance and are accompanied by itching, causing psychological stress.
2. Systemic complications
Some patients may develop psoriatic arthritis and cardiovascular disease, increasing disease complexity and treatment difficulty.
Immune reconstruction cell therapy regulates abnormal immune responses, restores normal immune system function, significantly reduces inflammation and clinical symptoms, and is highly safe. This therapy also promotes skin repair, helping patients maintain long-term disease stability.
1. Strong immune regulation
Cell therapy can precisely regulate the immune system, reduce autoimmune attacks, and relieve psoriasis symptoms.
2. Low side effects
Compared with traditional immunosuppressive drugs, cell therapy has fewer side effects and is more suitable for long-term management.
3. Promotes tissue repair
Enhances the skin’s self-repair ability, improves barrier function, and reduces recurrence rates.
In actual treatment, traditional regimens often face problems such as impaired immune function, increased infection risk, and slow recovery. To better support patients, improve treatment tolerance, and enhance quality of life, scientifically designed phased immune reconstruction plans are needed for different treatment cycles.
● Short-term plan: Rapidly enhance immunity through immune cell reinfusion to strengthen therapeutic effects.
● Mid-term plan: Reduce side effects of conventional therapies, promote recovery, and ensure completion of standardized regimens.
● Long-term plan: Gradually enhance immunity through immune cell reconstruction, gut immune reconstruction, elemental immune reconstruction, and immune nutrition reconstruction, improving quality of life and extending survival.
1. Topical medications
Including corticosteroids and vitamin D analogues, which relieve inflammation and itching, suitable for mild to moderate psoriasis.
2. Phototherapy
Ultraviolet light therapy suppresses excessive skin proliferation and controls disease progression.
3. Oral immunosuppressants
Suitable for moderate to severe patients, regulating immune responses, but requiring side effect monitoring.
4. Biologics
Target specific immune molecules, with remarkable efficacy, though relatively high cost.
5. Anti-inflammatory drugs
Reduce inflammation and relieve symptoms.
6. Moisturizers and skin care
Provide supportive care, preventing skin dryness and damage.
7. Traditional Chinese medicine
Helps regulate immunity and constitution, serving as an adjunct to relieve symptoms.
8. Lifestyle management
Diet modification, quitting smoking and alcohol, and psychological support help control the condition.
As a chronic immune-mediated skin disease, psoriasis severely impacts patients’ quality of life. Timely and scientific treatment is essential. Experts at United Life International Medical Center emphasize that cell therapy brings new treatment prospects for psoriasis, effectively controlling the disease and improving patients’ quality of life. Future treatment approaches will become increasingly diversified and precise.